Article info
Cooperative Group: Minority Opinion — The Ovarian Cancer Consensus Conference
Neoadjuvant Chemotherapy Cannot Be Regarded as Adequate Routine Therapy Strategy of Advanced Ovarian Cancer
- Address correspondence and reprint requests to Andreas du Bois, PhD, MD, Chairman, Department of Gynecology & Gynecologic Oncology, Kliniken Essen Mitte (KEM), Henricistrasse 92, Essen, Germany. E-mail: Prof.duBois@googlemail.com.
Citation
Neoadjuvant Chemotherapy Cannot Be Regarded as Adequate Routine Therapy Strategy of Advanced Ovarian Cancer
Publication history
- Received February 3, 2011
- First published February 1, 2012.
Online issue publication
February 26, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2012 by IGCS and ESGO